← Open Payments lookup

JILL LAIBINIS: Open Payments

NPI 1689397754 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,979 in 100 payments from 12 companies in 2025. Trend: 2023 $585 · 2024 $1,057 · 2025 $1,979

Food & beverage: $1,979
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$512
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$305
Janssen Pharmaceuticals, Inc9$251
ABBVIE INC.15$196
Otsuka America Pharmaceutical, Inc.10$177
Neurocrine BioSciences, Inc.13$145
Alkermes, Inc.8$145
E.R. Squibb & Sons, L.L.C.10$145
Vanda Pharmaceuticals Inc.2$34
Supernus Pharmaceuticals, Inc.2$31

Products named: UZEDY, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, AUSTEDO XR, INGREZZA, COBENFY, ARISTADA.

Industry payments across PA — which companies pay providers there.